TOOsonix, MDR

TOOsonix receives MDR CE Mark for its new oncology and dermatology device

Published on 08/07/2025 at 18:04 | prnewswire.co.uk

TOOsonix A/S Canada Spain France Denmark United Kingdom United States of America Germany

en | boerse | 67977248 |